| Characteristics | Total (N = 91) | Han population (N = 67) | Tibetan population (N = 24) | value |
| Age, years# | 65.36 ± 12.44 | 65.99 ± 12.25 | 63.63 ± 13.06 | 0.428 | Height (m)# | 1.68 ± 0.08 | 1.68 ± 0.09 | 1.66 ± 0.08 | 0.251 | Weight (Kg)# | 68.12 ± 10.75 | 68.88 ± 11.05 | 66.00 ± 9.80 | 0.262 | BMI (Kg/m2)# | 24.11 ± 2.71 | 24.19 ± 2.74 | 23.91 ± 2.68 | 0.663 | Oxygen saturation (%) | 90.0 (89.0, 93.0) | 91.0 (89.0, 93.0) | 90.0 (90.0, 92.0) | 0.816 | SBP (mmHg)# | 126.9 ± 24.4 | 128.7 ± 22.3 | 122.1 ± 29.4 | 0.328 | DBP (mmHg)# | 74.0 ± 13.5 | 73.9 ± 12.3 | 74.1 ± 16.8 | 0.960 | Heart rate# | 76.8 ± 15.5 | 78.5 ± 15.0 | 72.1 ± 16.2 | 0.080 | White blood cell | 7.20 (5.70, 11.09) | 7.05 (5.55, 10.96) | 7.88 (6.64, 11.33) | 0.471 | Red blood cell | 4.77 (4.26, 5.31) | 4.75 (4.40, 5.39) | 4.78 (4.03, 5.22) | 0.365 | Hemoglobin# | 151.1 ± 24.2 | 153.2 ± 21.5 | 145.0 ± 30.2 | 0.156 | Glycosylated hemoglobin | 5.81 (5.47, 6.70) | 5.78 (5.46, 6.70) | 5.95 (5.59, 6.95) | 0.418 | PT | 12.0 (11.5, 12.6) | 11.9 (11.4, 12.5) | 12.2 (11.9, 13.4) | 0.010 | APTT | 27.6 (25.4, 31.2) | 27.5 (25.4, 30.8) | 30.7 (25.9, 32.8) | 0.072 | ALT | 30.0 (19.0, 54.0) | 29.0 (19.0, 54.0) | 38.0 (17.0, 66.8) | 0.496 | AST | 38.0 (22.0, 159.0) | 34.0 (21.0, 159.0) | 44.5 (22.3, 258.5) | 0.438 | AST/ALT | 1.2 (0.8, 2.4) | 1.3 (0.9, 2.8) | 1.1 (0.7, 2.1) | 0.355 | Urea nitrogen | 6.07 (4.98, 8.10) | 5.87 (4.97, 7.58) | 7.16 (5.99, 10.68) | 0.014 | Creatinine | 84.0 (67.0, 94.0) | 82.0 (67.0, 93.0) | 84.5 (75.3, 114.5) | 0.242 | Glomerular filtration rate (mL/min × 1.73 m2)# | 78.2 ± 25.2 | 80.6 ± 24.9 | 70.9 ± 25.1 | 0.109 | Albumin | 37.8 (34.8, 40.6) | 38.0 (35.2, 40.7) | 36.6 (32.7, 38.3) | 0.085 | Total cholesterol (mmol/L)# | 4.13 ± 1.12 | 4.13 ± 1.03 | 4.02 ± 1.37 | 0.699 | Triglyceride | 1.42 (0.90, 2.14) | 1.59 (0.90, 2.18) | 1.32 (0.88, 1.87) | 0.418 | TSH | 1.60 (0.86, 2.82) | 1.62 (0.85, 2.70) | 1.30 (0.88, 2.91) | 0.571 |
| Sex, n (%) | | | | 0.475 | Male | 63 (69.2) | 45 (67.2) | 18 (75.0) | | Female | 28 (30.8) | 22 (32.8) | 6 (25.0) | |
| Aspirin resistance, n (%) | | | | 0.660 | No | 42 (46.2) | 30 (44.8) | 12 (50.0) | | Yes | 49 (53.8) | 37 (55.2) | 12 (50.0) | |
| Smoking history, n (%) | | | | 0.039 | No | 52 (57.1) | 34 (50.7) | 18 (75.0) | | Yes | 39 (42.9) | 33 (49.3) | 6 (25.0) | |
| Coronary heart disease type, n (%) | | | | 0.932 | STEMI | 42 (46.2) | 31 (46.3) | 11 (45.8) | | NSTEMI | 12 (13.2) | 8 (11.9) | 4 (16.7) | | SAP | 15 (16.5) | 11 (16.4) | 4 (16.7) | | UA | 22 (24.2) | 17 (25.4) | 5 (20.8) | |
| Hypertension, n (%) | | | | 0.291 | No | 30 (33.0) | 20 (29.9) | 10 (41.7) | | Yes | 61 (66.7) | 47 (70.1) | 14 (58.3) | |
| Diabetes, n (%) | | | | 0.374 | No | 45 (49.5) | 35 (52.2) | 10 (41.7) | | Yes | 46 (50.5) | 32 (47.8) | 14 (58.3) | |
| Stroke, n (%) | | | | 0.473 | No | 59 (64.8) | 42 (62.7) | 17 (70.8) | | Yes | 32 (35.2) | 25 (37.3) | 7 (29.2) | |
| Hyperlipidaemia, n (%) | | | | 0.907 | No | 54 (59.3) | 40 (59.7) | 14 (58.3) | | Yes | 37 (40.7) | 27 (40.3) | 10 (41.7) | |
| CYP2C192, n (%) | | | | 0.120 | GG | 61 (67.0) | 45 (67.2) | 16 (66.7) | | GA | 24 (26.4) | 16 (23.9) | 8 (33.3) | | AA | 6 (6.6) | 6 (9.0) | 0 (0.0) | |
| CYP2C193, n (%) | | | | 0.527 | GG | 44 (48.4) | 34 (50.7) | 10 (41.7) | | GA | 26 (28.6) | 17 (25.4) | 9 (37.5) | | AA | 21 (23.0) | 16 (23.9) | 5 (20.8) | |
| CYP2C1917, n (%) | | | | 0.317 | GG | 57 (62.6) | 44 (65.7) | 13 (54.2) | | GA | 34 (37.4) | 23 (34.3) | 11 (45.8) | |
|
|